Govt. contests Centre’s ban on sale of oxytocin

Says the drug is an essential part of obstetric procedures

August 10, 2018 09:06 am | Updated 09:07 am IST - CHENNAI

Oxytocin is being misused in the dairy sector, say officials. File photo

Oxytocin is being misused in the dairy sector, say officials. File photo

The Tamil Nadu government has contested the Centre’s ban on the retail sale of oxytocin. At the same time, it has made arrangements to ensure that there is no shortage of oxytocin in government hospitals in the State.

The Union Health Ministry had banned the sale of oxytocin and its formulations at retail medical shops from September 1.

 

Hospitals and clinics have to purchase oxytocin drug formulations directly from a public sector undertaking - Karnataka Antibiotics and Pharmaceuticals Limited (KAPL), Bengaluru.

On Monday, the Centre held a meeting via video conference to discuss issues relating to procurement of oxytocin from KAPL. Officials of the Health Department here took part in the meeting and put forth their views.

Life-saving injection

“Oxytocin is a life-saving injection. It is routinely used soon after delivery to stop post partum haemorrhage, treatment of post partum haemorrhage, induction of labour and augmentation of labour,” said T. K. Shaanthy Gunasingh, president of Obstetric and Gynaecological Society of Southern India.

According to officials, oxytocin was misused in the dairy sector to increase milk yield, and hence, the Centre decided to ban its retail sale.

However, an official of the Tamil Nadu Medical Services Corporation said that Tamil Nadu had clearly contested the Centre’s move.

Regulator’s issue

They have raised three points of contention regarding regulation, supplier and cost. “If the government of India is worried about the misuse of oxytocin, it is up to the regulators to regulate its sale. It should be handled by the Department of Animal Husbandry and drug regulators. The Health Department has no issue with oxytocin,” he said.

Another point of disagreement was in allotting supply to one PSU. “There is serious objection from TNMSC on the Centre’s strategy to entrust the supply for the entire country with one company. We have said that there should be a minimum of three manufacturers to supply oxytocin,” he added.

The third point of contention was the price.

“The price with KAPL is ₹15.88 and this will amount to loss for the State government,” the official added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.